These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 3288852)
21. [Controlled clinical study on the therapeutic efficacy of Enterococcus acidogenus HS 15 of human origin in diarrheic enterocolitis]. Maggi CA; Corigliano P Minerva Dietol Gastroenterol; 1985; 31(4):603-8. PubMed ID: 3937071 [No Abstract] [Full Text] [Related]
22. [Therapeutic use of hemoderivatives]. Yurrebaso Eguilior N; Mota Villaplana FM; Montoro Ronsano JB Sangre (Barc); 1997 Oct; 42(5):423-7. PubMed ID: 9424747 [No Abstract] [Full Text] [Related]
24. The discovery of natural products with therapeutic potential. Biotechnology; 1994; 26():1-461. PubMed ID: 7749301 [No Abstract] [Full Text] [Related]
25. Natural products as drug leads: an old process or the new hope for drug discovery? Kingston DG; Newman DJ IDrugs; 2005 Dec; 8(12):990-2. PubMed ID: 16320131 [TBL] [Abstract][Full Text] [Related]
26. [Biosimilar: can we manage biopharmaceutical heterogeneity?]. Ranieri E G Ital Nefrol; 2008; 25(3):275. PubMed ID: 18473296 [No Abstract] [Full Text] [Related]
27. Research and development of biological products in China. Zhu J Chin Med J (Engl); 1995 Jul; 108(7):490-2. PubMed ID: 7555264 [No Abstract] [Full Text] [Related]
28. [Therapeutic possibilities of royal jelly]. Fossati C Clin Ter; 1972 Aug; 62(4):377-87. PubMed ID: 4508823 [No Abstract] [Full Text] [Related]
29. [Use of biologicals in psoriasis]. Friedrich M; Philipp S; Sabat R; Asadullah K; Sterry W Z Rheumatol; 2003 Oct; 62(5):439-49. PubMed ID: 14579031 [TBL] [Abstract][Full Text] [Related]
30. Applicability of phase I trial results in the design of phase II and III biological response modifier trials. Pinsky CM Cancer Treat Rep; 1985 Oct; 69(10):1171-3. PubMed ID: 4042095 [No Abstract] [Full Text] [Related]
31. [Biologic therapy of inflammatory bowel disease]. Baumgart DC; Wiedenmann B; Dignass AU Z Gastroenterol; 2003 Oct; 41(10):1017-32. PubMed ID: 14562200 [TBL] [Abstract][Full Text] [Related]
32. Toxicity as a result of immunostimulation by biologics. Gribble EJ; Sivakumar PV; Ponce RA; Hughes SD Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):209-34. PubMed ID: 17428152 [TBL] [Abstract][Full Text] [Related]
33. Clinical application of lymphokines and cytokines. Immunobiology; 1986 Sep; 172(3-5):157-458. PubMed ID: 3542808 [No Abstract] [Full Text] [Related]
35. Natural products and dietary prevention of cancer. Rimando AM; Suh N Mol Nutr Food Res; 2008 Jun; 52 Suppl 1():S5. PubMed ID: 18567050 [No Abstract] [Full Text] [Related]
36. The role of biologicals in early rheumatoid arthritis. Haque UJ; Bathon JM Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):179-89. PubMed ID: 15588978 [TBL] [Abstract][Full Text] [Related]
37. Natural products and molecular therapy. Closing remarks. Tshabalala-Msimang M Ann N Y Acad Sci; 2005 Nov; 1056():494-6. PubMed ID: 16387712 [No Abstract] [Full Text] [Related]
38. [Alternative medicine. Is it time to take the biological medicine seriously?]. Hagelsten JO Sygeplejersken; 1986 Sep; 86(38):42-3. PubMed ID: 3639666 [No Abstract] [Full Text] [Related]
39. [Clinical research on a biological preparation with stimulating effect on the adrenocortical secretion]. Mascaretti L Minerva Med; 1973; 64(45):2365-70. PubMed ID: 4582182 [No Abstract] [Full Text] [Related]
40. Improving the science for botanical and dietary supplements. Geller SE Altern Ther Health Med; 2009; 15(1):16-7. PubMed ID: 19161043 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]